|
|
 |
|
Viewing report
|
|
|
|
Infectious Diseases Vaccine Market Overview: Key Companies & Strategies - In Times of Crisis, Big Pharma turns to Vaccines
Datamonitor, Dec 2008, Pages: 267
Introduction
Long being regarded as an unattractive market, vaccines have re-emerged as successful growth driver for Big Pharma. The launch and rapid uptake of novel, high-price products such as Wyeths Prevnar or Merck & Cos Gardasil, along with the emergence of novel vaccine technologies and favourable legislation have brought vaccines back into the main focus of pharmaceutical and biotech companies.
Scope
- Market overview with current market assessment in terms of leading players, brands and geographies
- In-depth analyses of the leading 5 players portfolios, R&D pipelines, sales trends, geographic spread, licensing patterns and strategic outlook
- Discussion of key developments shaping the sector: new technologies, indications and geographies
- Snapshot profiles of second tier companies in the sector: strength in specialties
Highlights
With the exception of influenza, only two to three vaccine manufacturers compete for each disease. This lack of competition combined with public health requirements to guarantee a stable supply of vaccines has resulted in a recent upward shift of vaccine prices for specialty vaccines.
The most significant threat to the oligopoly of the Big 5 in the vaccines market comes from companies from emerging markets, which have large manufacturing capacities for biologics and are able to produce even complex substances like vaccines at low costs.
While vaccine sales have grown at a CAGR of 32% between 2004 and 2007 and shown an annual growth rate of 46% between 2006 and 2007, overall pharmaceutical sales have grown much more slowly, with both the 2004-2007 CAGR as well as the growth rate between 2006 and 2007 only reaching 8%.
Reasons to Purchase
- Get a comprehensive, insightful commercial overview of the vaccines market
- Learn about the strategies of the Big 5 players, their strengths, weaknesses, similarities and differences
- Gain insight into the future directions and growing strategic importance of vaccines for Big Pharma
Customers who bought this item also bought
Pipeline and Commercial Insight: Pneumococcal and Meningococcal Vaccines
World Vaccines Market: Vaccine Segments Analysis, Vaccine Cases and Future Forecast
Infectious Disease Vaccines - Unmet Needs and Opportunities for Pharma
Advances in Vaccine Technology and Delivery
Global Vaccine Market Outlook (2007-2010)
Opportunity Analysis of H1N1 (swine flu) Vaccination Market
Vaccine Market Access in China - M&A paves the way for foreign companies
The Immune/Inflammatory Pipeline: A Strategic Review
Veterinary Vaccines - Global Strategic Business Report
Chemotherapy Market Insights, 2006-2016: A Critical Analysis of Cancer Research, Treatments, Pipelines, and Commercial Opportunities
|
|
|
|
